|
[1]
|
Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation
Expert Opinion on Drug Delivery,
2024
DOI:10.1080/17425247.2024.2343882
|
|
|
|
|
[2]
|
Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation
Expert Opinion on Drug Delivery,
2024
DOI:10.1080/17425247.2024.2343882
|
|
|
|
|
[3]
|
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects
ASSAY and Drug Development Technologies,
2023
DOI:10.1089/adt.2022.102
|
|
|
|
|
[4]
|
A light-responsive, self-immolative linker for controlled drug delivery via peptide- and protein-drug conjugates
Chemical Science,
2019
DOI:10.1039/C9SC03016F
|
|
|
|
|
[5]
|
Cytotoxic Payloads for Antibody – Drug Conjugates
2019
DOI:10.1039/9781788012898-00137
|
|
|
|
|
[6]
|
Cytotoxic Payloads for Antibody – Drug Conjugates
2019
DOI:10.1039/9781788012898-00137
|
|
|
|
|
[7]
|
Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
Drug Delivery,
2018
DOI:10.1080/10717544.2018.1435746
|
|
|
|
|
[8]
|
Augmenting the cytotoxicity of oleic acid-protein complexes: Potential of target-specific antibodies
Biochimie,
2017
DOI:10.1016/j.biochi.2017.03.013
|
|
|
|
|
[9]
|
Intracellular Delivery III
Fundamental Biomedical Technologies,
2016
DOI:10.1007/978-3-319-43525-1_16
|
|
|
|